|
Incannex Healthcare Inc (NASDAQ: IXHL) |
|
Incannex Healthcare Inc
IXHL's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Incannex Healthcare Inc growth rates, revenue grew
in IV. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.73 %
• More on IXHL's Growth
|
|
Incannex Healthcare Inc realized a net loss in trailing twelve months.
Incannex Healthcare Inc realized cash reduction of $ -2.01 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 379.59.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.16.
• More on IXHL's Valuation
|
|
|
|
|
Incannex Healthcare Inc realized net loss in trailing twelve months.
Incannex Healthcare Inc realized cash outflow of $ -2.01per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 379.59.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.16.
Incannex Healthcare Inc Price to Book Ratio is at 2.5 lower than Industry Avg. of 79.2. and higher than S&P 500 Avg. of 0.01
• More on IXHL's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com